MARISA KONISHI: Open Payments
NPI 1649945593 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 49 payments from 15 companies in 2025. Trend: 2023 $169 · 2024 $1,732 · 2025 $1,584
Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $379 |
| Novo Nordisk Inc | 8 | $289 |
| PFIZER INC. | 10 | $245 |
| Edwards Lifesciences Corporation | 1 | $137 |
| Lilly USA, LLC | 4 | $86 |
| ABBVIE INC. | 3 | $78 |
| Exact Sciences Corporation | 3 | $77 |
| Inspire Medical Systems, Inc. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $48 |
Products named: FARXIGA, Wegovy, ELIQUIS, BREZTRI, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, MOUNJARO, INSPIRE, JARDIANCE.
Industry payments across VA — which companies pay providers there.
